Population
Patients with resistant hypertension
Comparison
Baxdrostat integrated with precision medicine… vs Traditional empirical treatment approaches
Design
Editorial
Key result
Baxdrostat represents a promising antihypertensive agent and potential cornerstone for precision hypertension management by leveraging pharmacogenomics, omics biomarkers, and digital health technologies.
Authors
Loading...
Should not yet change hypertension practice; leaves open precision strategies pending randomized validation.
Baxdrostat represents a potential cornerstone for precision hypertension management when integrated with pharmacogenomics, omics biomarkers, and digital health technologies.
Amjad et al. (2026) conducted a letter in resistant hypertension. baxdrostat was evaluated. Baxdrostat represents a promising antihypertensive agent and potential cornerstone for precision hypertension management by leveraging pharmacogenomics, omics biomarkers, and digital health technologies.